129 related articles for article (PubMed ID: 35092722)
1. Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial.
Klingenberg R; Stähli BE; Heg D; Denegri A; Manka R; Kapos I; von Eckardstein A; Carballo D; Hamm CW; Vietheer J; Rolf A; Landmesser U; Mach F; Moccetti T; Jung C; Kelm M; Münzel T; Pedrazzini G; Räber L; Windecker S; Matter CM; Ruschitzka F; Lüscher TF
Am Heart J; 2022 May; 247():33-41. PubMed ID: 35092722
[TBL] [Abstract][Full Text] [Related]
2. Mammalian Target of Rapamycin Inhibition in Patients With ST-Segment Elevation Myocardial Infarction.
Stähli BE; Klingenberg R; Heg D; Branca M; Manka R; Kapos I; Müggler O; Denegri A; Kesterke R; Berger F; Stehli J; Candreva A; von Eckardstein A; Carballo D; Hamm C; Landmesser U; Mach F; Moccetti T; Jung C; Kelm M; Münzel T; Pedrazzini G; Räber L; Windecker S; Templin C; Matter CM; Lüscher TF; Ruschitzka F
J Am Coll Cardiol; 2022 Nov; 80(19):1802-1814. PubMed ID: 36049557
[TBL] [Abstract][Full Text] [Related]
3. Colchicine for Left Ventricular Infarct Size Reduction in Acute Myocardial Infarction: A Phase II, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Protocol - The COVERT-MI Study.
Bresson D; Roubille F; Prieur C; Biere L; Ivanes F; Bouleti C; Dubreuil O; Rioufol G; Boutitie F; Sideris G; Elbaz M; Bochaton T; De Bourguignon C; El Jonhy N; Dufay N; Dhelens C; Croisille P; Prunier F; Angoulvant D; Ovize M; Maucort-Boulch D; Mewton N
Cardiology; 2021; 146(2):151-160. PubMed ID: 33582664
[TBL] [Abstract][Full Text] [Related]
4. Effects of Compound Danshen Dripping Pills on Ventricular Remodeling and Cardiac Function after Acute Anterior Wall ST-Segment Elevation Myocardial Infarction (CODE-AAMI): Protocol for a Randomized Placebo-Controlled Trial.
Wu YJ; Deng B; Wang SB; Qiao R; Zhang XW; Lu Y; Wang L; Gu SZ; Zhang YQ; Li KQ; Yu ZL; Wu LX; Zhao SB; Zhou SL; Yang Y; Wang LS
Chin J Integr Med; 2023 Dec; 29(12):1059-1065. PubMed ID: 37656413
[TBL] [Abstract][Full Text] [Related]
5. Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial.
Najjar SS; Rao SV; Melloni C; Raman SV; Povsic TJ; Melton L; Barsness GW; Prather K; Heitner JF; Kilaru R; Gruberg L; Hasselblad V; Greenbaum AB; Patel M; Kim RJ; Talan M; Ferrucci L; Longo DL; Lakatta EG; Harrington RA;
JAMA; 2011 May; 305(18):1863-72. PubMed ID: 21558517
[TBL] [Abstract][Full Text] [Related]
6. Calcium/Calmodulin-Dependent Protein Kinase II Delta Inhibition and Ventricular Remodeling After Myocardial Infarction: A Randomized Clinical Trial.
Boyle AJ; Schultz C; Selvanayagam JB; Moir S; Kovacs R; Dib N; Zlotnick D; Al-Omary M; Sugito S; Selvarajah A; Collins N; McLachlan G
JAMA Cardiol; 2021 Jul; 6(7):762-768. PubMed ID: 33851966
[TBL] [Abstract][Full Text] [Related]
7. Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction.
Mewton N; Roubille F; Bresson D; Prieur C; Bouleti C; Bochaton T; Ivanes F; Dubreuil O; Biere L; Hayek A; Derimay F; Akodad M; Alos B; Haider L; El Jonhy N; Daw R; De Bourguignon C; Dhelens C; Finet G; Bonnefoy-Cudraz E; Bidaux G; Boutitie F; Maucort-Boulch D; Croisille P; Rioufol G; Prunier F; Angoulvant D
Circulation; 2021 Sep; 144(11):859-869. PubMed ID: 34420373
[TBL] [Abstract][Full Text] [Related]
8. A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCI.
Adlam D; Zarebinski M; Uren NG; Ptaszynski P; Oldroyd KG; Munir S; Zaman A; Contractor H; Kiss RG; Édes I; Szachniewicz J; Nagy GG; Garcia MJ; Tomcsanyi J; Irving J; Sharp ASP; Musialek P; Lupkovics G; Shirodaria C; Selvanayagam JB; Quinn P; Ng L; Roth M; Insko MA; Haber B; Hill S; Siegel L; Tulloch S; Channon KM
Int J Cardiol; 2022 Jan; 347():1-7. PubMed ID: 34774885
[TBL] [Abstract][Full Text] [Related]
9. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
[TBL] [Abstract][Full Text] [Related]
10. Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention.
Roolvink V; Ibáñez B; Ottervanger JP; Pizarro G; van Royen N; Mateos A; Dambrink JE; Escalera N; Lipsic E; Albarran A; Fernández-Ortiz A; Fernández-Avilés F; Goicolea J; Botas J; Remkes W; Hernandez-Jaras V; Kedhi E; Zamorano JL; Navarro F; Alfonso F; García-Lledó A; Alonso J; van Leeuwen M; Nijveldt R; Postma S; Kolkman E; Gosselink M; de Smet B; Rasoul S; Piek JJ; Fuster V; van 't Hof AWJ;
J Am Coll Cardiol; 2016 Jun; 67(23):2705-2715. PubMed ID: 27050189
[TBL] [Abstract][Full Text] [Related]
11. Relation of Left Ventricular Mass and Infarct Size in Anterior Wall ST-Segment Elevation Acute Myocardial Infarction (from the EMBRACE STEMI Clinical Trial).
Daaboul Y; Korjian S; Weaver WD; Kloner RA; Giugliano RP; Carr J; Neal BJ; Chi G; Cochet M; Goodell L; Michalak N; Rusowicz-Orazem L; Alkathery T; Allaham H; Routray S; Szlosek D; Jain P; Gibson CM
Am J Cardiol; 2016 Sep; 118(5):625-31. PubMed ID: 27392509
[TBL] [Abstract][Full Text] [Related]
12. Platelet inhibition to target reperfusion injury trial: Rationale and study design.
Bulluck H; Chan MHH; Bryant JA; Chai P; Chawla A; Chua TS; Chung YC; Fei G; Ho HH; Ho AFW; Hoe AJ; Imran SS; Lee CH; Lim SH; Liew BW; Yun PLZ; Hock MOE; Paradies V; Roe MT; Teo L; Wong AS; Wong E; Wong PE; Watson T; Chan MY; Tan JW; Hausenloy DJ
Clin Cardiol; 2019 Jan; 42(1):5-12. PubMed ID: 30421441
[TBL] [Abstract][Full Text] [Related]
13. Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial.
Nazir SA; McCann GP; Greenwood JP; Kunadian V; Khan JN; Mahmoud IZ; Blackman DJ; Been M; Abrams KR; Shipley L; Wilcox R; Adgey AA; Gershlick AH
Eur Heart J; 2016 Jun; 37(24):1910-9. PubMed ID: 27147610
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of early cardiac magnetic resonance imaging functional and geometric indexes for adverse left ventricular remodelling in patients with anterior ST-segment elevation myocardial infarction: A report from the CIRCUS study.
Pezel T; Besseyre des Horts T; Schaaf M; Croisille P; Bière L; Garcia-Dorado D; Jossan C; Roubille F; Cung TT; Prunier F; Meyer E; Amaz C; Derumeaux G; de Poli F; Hovasse T; Gilard M; Bergerot C; Thibault H; Ovize M; Mewton N
Arch Cardiovasc Dis; 2020 Nov; 113(11):710-720. PubMed ID: 33160891
[TBL] [Abstract][Full Text] [Related]
15. Rationale and design of the Cyclosporine to ImpRove Clinical oUtcome in ST-elevation myocardial infarction patients (the CIRCUS trial).
Mewton N; Cung TT; Morel O; Cayla G; Bonnefoy-Cudraz E; Rioufol G; Angoulvant D; Guerin P; Elbaz M; Delarche N; Coste P; Vanzetto G; Metge M; Aupetit JF; Jouve B; Motreff P; Tron C; Labeque JN; Steg PG; Cottin Y; Range G; Clerc J; Coussement P; Prunier F; Moulin F; Roth O; Belle L; Dubois P; Barragan P; Gilard M; Piot C; Colin P; Morice MC; Monassier JP; Ider O; Dubois-Randé JL; Unterseeh T; Lebreton H; Beard T; Blanchard D; Grollier G; Malquarti V; Staat P; Sudre A; Hansson MJ; Elmer E; Boussaha I; Jossan C; Torner A; Claeys M; Garcia-Dorado D; Ovize M;
Am Heart J; 2015 Jun; 169(6):758-766.e6. PubMed ID: 26027612
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous β-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY β-blocker administration before primary PCI in patients with ST-elevation myocardial infarction trial.
Roolvink V; Rasoul S; Ottervanger JP; Dambrink JH; Lipsic E; van der Horst IC; de Smet B; Kedhi E; Marcel Gosselink AT; Piek JJ; Sanchez-Brunete V; Ibanez B; Fuster V; Van't Hof AW;
Am Heart J; 2014 Nov; 168(5):661-6. PubMed ID: 25440793
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of microvascular resistance index immediately after primary percutaneous coronary intervention on left ventricular remodeling in patients with reperfused anterior acute ST-segment elevation myocardial infarction.
Kitabata H; Kubo T; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Kashiwagi M; Ozaki Y; Shiono Y; Shimamura K; Orii M; Hirata K; Tanaka A; Imanishi T; Akasaka T
JACC Cardiovasc Interv; 2013 Oct; 6(10):1046-54. PubMed ID: 24156965
[TBL] [Abstract][Full Text] [Related]
18. Effect of comprehensive remote ischemic conditioning in anterior ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Design and rationale of the CORIC-MI randomized trial.
Song L; Yan H; Zhou P; Zhao H; Liu C; Sheng Z; Tan Y; Yi C; Li J; Zhou J
Clin Cardiol; 2018 Aug; 41(8):997-1003. PubMed ID: 29726013
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
20. Rationale and design of EXPLORE: a randomized, prospective, multicenter trial investigating the impact of recanalization of a chronic total occlusion on left ventricular function in patients after primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
van der Schaaf RJ; Claessen BE; Hoebers LP; Verouden NJ; Koolen JJ; Suttorp MJ; Barbato E; Bax M; Strauss BH; Olivecrona GK; Tuseth V; Glogar D; Råmunddal T; Tijssen JG; Piek JJ; Henriques JP;
Trials; 2010 Sep; 11():89. PubMed ID: 20858263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
